Yes, pharmacovigilance requirements are integral to drug registration in Singapore. The Health Sciences Authority mandates a risk management plan and ongoing safety monitoring. Companies must report adverse drug reactions and submit periodic safety update reports to ensure drug safety and efficacy throughout its lifecycle in the market.
